lipogenesis in hyperplastic human breast tissues.
IT HAS BEEN SHOWN that in human breast carcinoma the level of fatty acid is 2-3 times that in normal mammary gland (Hilf et al., 1970a (Hilf et al., , 1973 , which is consistent with the fact that activities of many cytoplasmic and mitochondrial enzymes in cancerous tissues are 10-100-fold higher than in normal tissue (Hilf et al., 1970b (Hilf et al., , 1969 . However, the enzyme apparently involved in lipogenesis, ATP-citrate oxaloacetate lyase, showed no apparent rise (Hilf et al., 1970b) , making it difficult to explain the tracer studies that established the role of citrate as a fatty-acid precursor (Daikuhara et al., 1968; Foster & Srere, 1968; Bowman et al., 1970) .
In view of the fact that these previous experiments were carried out with tissue that had been frozen before the enzyme determinations were made (Hilf et al., 1969 (Hilf et al., , 1970a (Hilf et al., , b, 1973 Smith et al., 1966; Smith & Abraham, 1970) , it was postulated that such procedures could adversely affect this activity, as well as that of other enzymes involved in lipogenesis. Therefore, it was of interest to determine the activities of the "lipogenic enzymes" involved in fatty-acid synthesis from carbohydrate sources in normal, fibrocystic and cancerous breast tissues that had not been previously frozen. In addition, a comparison was made between the enzyme activities of two groups of fibrocystic breast tissues acting as the substratum for benign or malignant tumours.
MATERIALS AND METHODS
The breast tissue and tumour specimens obtained during dissection at operation were placed immediately in ice-cold 0-15M KC1.
The diameter of the tumours varied from 2 to 10 cm. The character of the tumours and surrounding tissues was determined by contemporary histopathological examination of fresh frozen samples taken from 3-5 sites. The pieces lying close to those tested histopathologically were dissected for enzymatic studies. The total fresh weight of the collected samples ranged from 0-3-0-6 g, depending on the size of the tumour. Samples of breast tissue not invaded by the carcinoma were taken from places as far as possible from the tumours, to avoid contamination by disseminating cancerous cells. The quality of this tissue was also evaluated by contemporary histological examination. For a final histological diagnosis the samples were stabilized in paraffin blocks and stained with haematoxylin and eosin.
For the determination of enzymatic activities, samples were cut into small pieces with scissors, placed in 5 volumes of ice-cold 0-2M KC1 containing 0-005M Tris-HCI buffer (pH 7.4) and 0001M dithiothreitol, and homogenized in a glass homogenizer with a Teflon plug at 600 rev/min for 10 min in an ice bath. The supernatants were obtained by centrifugation at 20,000 g for 45 min at 2-40C.
During some of the radical mastectomies, axillary metastatic nodules were taken and treated as described above to obtain histopathological diagnosis and cytoplasm for enzyme determinations.
The enzymatic activities were determined according to the following procedures: hexokinase (ATPv: D-hexose 6-phosphotransferase, EC-2.7.4.1), phosphofructokinase (ATPv: Dfructose 6-phosphotransferase, EC-2.7.1.11) and lactic dehydrogenase (L-lactate NADoxidoreductase EC-1.1.1.27) (Kornberg, 1955) ; NADP-isocitrate dehydrogenase (threo-DV5-isocitrate : NADP-oxidoreductase, decarboxylating, EC-1.1.1.42) (Plaut,1962) ; malate NADP dehydrogenase (L-malate NADP oxidoreductase, decarboxylating, EC -1.1.1.40) (Ballard & Hanson, 1967) and ATP-citrate lyase (ATP-citrate oxaloacetate lyase: (pro-3S-CH2 COO-acetyl CoA, ATP dephosphorylating, EC-4.1.3.8) (Srere, 1959) . The determinations were carried out at 37°C in a standard volume of 0 5 ml by the measurement of the rate of reduction or oxidation of nicotinamide adenine dinucleotide at 340 nm in a Zeiss PQ-4 spectrophotometer with multispeed recorder. Full-scale deflection of the pen of the recorder was expanded to an absorbance difference equal to 0-2. The reaction rate was linear with time for 10 min and was proportional to the amount of supernatant. The enzymatic activities were expressed as ,tmol of reduced or oxidized nicotinamid adenine dinucleotide/ min/I g fresh tissue.
The amount of protein was determined according to Gornall et al. (1949) . Reagents:
CoA, NADH, NADP, DL-isocitric acid, fructose 6-phosphate, malate dehydrogenase, and lactate dehydrogenase were obtained from Sigma (St Louis, Mo, USA); other reagents were products of Polskie Odczynniki Chemiczne (Gliwice, Poland).
RESULTS
The tumours were classified into 3 groups according to the histopathological findings: localized fibrocystic disease, fibroadenoma and carcinoma of the breast (Table I) . Normal samples were taken from the breast after removal of tumours that were histopathologically acceptable. The protein concentration in cytosols from benign tumours (except for mastopathic breast from behind the tumours) did not differ significantly from that found in cytosol from normal tissue (Table II) . On the other hand the protein concentration in cytosol from carcinoma was about 70%o higher than in normal breast.
The activities of hexokinase (HX), phosphofructokinase (PFK), lactate dehydrogenase (LDH), malate NADP dehydrogenase (ME) and isocitrate NADP dehydrogenase (ICD) in mastopathic breast tissues (Table II, Groups 2 and 3) did not differ significantly from values obtained with "normal" breast tissues. There was a statistically significant increase of 690% in LDH activity in fibrocystic breast (Group 2b). The activities of PFK, HX and ME in breast fibroadenoma (Group 3) were similar to those determined in "normal" breast. In contrast ICD and LDH activities increased 33000 and 145% (P<0-01) respectively. In the group of nonmalignant localized fibrocystic disease (Group 2c), significant increases of activity were found for LDH (78%) and HX (326%) (P<0 05).
No significant differences were found between fibrocystic breasts of Groups 2a and 2b.
The activities of all enzymes tested from carcinomas were significantly higher than both the "normal" and the fibrocystic extratumoral gland. This increase varied from 4 to 60 times in the following sequence: PFK<ME < HX< LDH <ICD <ATP-citrate lyase (CCE) (Group 4). The rise in CCE activity is of particular interest. The activity of this enzyme in control tissues was very low, being 0 0017 ,umol/min/g of fresh tissue, and was elevated 13-and 26-fold in the cytoplasm of mastopathic breasts surrounding benign tumours and carcinomas respectively.
Increase in CCE activity was also shown in fibroadenomas (Group 3). In these samples the enzyme activity was 42 x the controls. It was also significantly higher than the activity of CCE in fibrocystic mammary glands (Group 2).
It should be pointed out that the activity of ATP-citrate lyase in carcinomas was 160X that in controls, and also [4] [5] [6] [7] x that in benign tumours.
The histology of metastatic axillary lymph nodules was identical to that of the Tables II and III . It should be stressed that the statistical significance of differences between various experimental groups are the same regardless of the method by which the activity was calculated (unpublished data).
The data presented in this paper confirm the results of earlier reports (Hilf et al., 1969 (Hilf et al., , 1970a (Hilf et al., ,b, 1973 ) that indicate significant biochemical differences between "normal", fibrocystic and cancerous tissues. The data presented in Table II indicate that increases in the activities of glycolytic enzymes are not the most characteristic feature of neoplastic outgrowth. Rather a much higher relative increase in activity was observed for ATP citrate lyase and isocitrate NADP dehydrogenase, which is consistent with the increases in lipogenesis found in these tissues.
The activity of citrate lyase in cancerous breast tissues determined by our method is 26 x that obtained by Hilf et al. (1970a) . On the other hand, in normal breast tissue although we sometimes could not even detect citrate lyase activity our values are on the average comparable to those of Hilf (1970a) . The activity of NADP-specific isocitrate dehydrogenase in tumours was 3 x that in Hilf's experiments (Table II) , whilst the activities of hexokinase, lactate dehydrogenase and malate NADP dehydrogenase were 2-3 5 x higher than those found by Hilf et al. (I 970a) and Smith et al. (1966) .
In normal breast, the activity of isocitrate dehydrogenase was half, and those of hexokinase and malate NADP dehydrogenase were 16 x and 4 x, respectively, activities reported by Hilf et al. (1970a) .
The differences observed in these enzymic activities may be related to the different experimental conditions used. Our investigations have been performed on soluble fractions obtained from homogenates of fresh unfrozen tissue cooled to 0°C. The homogenizing medium used was slightly hyperosmotic and contained the thiol group protecting agent, dithiothreitol. In the experiments reported by Hilf et al. (1970a) and by Smith et al. (1966) , freezing, thawing and homogenization in hypo-osmotic medium could disrupt the mitochondria and release some mitochondrial enzymes into the supernatant fraction, explaining the relatively higher cytosol activity of isocitrate NADP dehydrogenase which occurs in both intra-and extra-mitochondrial locations.
We have also shown that freezing and thawing can cause a marked decrease in the activity of the enzymes. Thus, by a combination of these factors, the rise in citrate lyase that was seen in our fibrocystic and tumour-bearing patients was apparently not observed earlier (Hilf et al., 1970; Smith et al., 1966) .
The demonstrated rise of ATP-citrate lyase is consistent with the postulated role of this enzyme as an acetyl-CoA donor (Daikuhara et al., 1968; Foster & Srere, 1968; Bowman et al., 1970) . It provides the final step of the metabolic pathways supplying acetyl-CoA for synthesis of cytoplasmic fatty acids in liver adipose tissue and lactating mammary glands (Daikuhara et al., 1968; Srere, 1965) . It has been shown in other physiological and pathological states that the change in rate of fatty-acid synthesis was accompanied by a change in citrate lyase activity (Smith & Abraham, 1970; Abraham & Chaikoff, 1965; Angielski & Szutowicz, 1967; Jones, 1967; Tepperman & Tepperman, 1965) .
A high increase of this enzyme activity has been seen in rat lactating mammary gland, when large amounts of triglycerides are excreted with milk (Bowman et al., 1970) .
Therefore it has been suggested that citrate lyase may be one of the ratelimiting steps of lipogenesis (Smith & Abraham, 1970) . On the other hand, some observations did not show a correlation between changes in citrate-lyase activity and the rate of fatty-acid synthesis (Foster & Srere, 1968; Goodridge, 1968) .
In "lipogenic" organs of the human adult, the activity of citrate lyase is very low, indicating that this metabolic pathway does not play an important role in fatty-acid metabolism in man (Shrago & Glennon, 1967) . However, in breast carcinoma, and to a lesser degree in fibrocystic mammary gland, there is high activity of this enzyme, despite a lack of milk production (Table II) . No data on the appearance of citrate lyase in normal lactating human breast are available. However, whatever the role of the citrate lvase in the neoplastic tissues may be, the demonstration of marked increase reaffirms its status as a lipogenic enzyme in these cells.
The relative increase of citrate lyase in breast carcinoma is the highest for all the enzymes tested. This high increase of citrate lyase is not only specific for breast carcinoma, but is also increased in human tumours of the central nervous system and liver. Citrate lyase also appears in the cervix uteri during neoplastic transformation of its epithelium (unpublished data). This enzymatic reaction in cancerous tissue may be to increase the supply of acetyl-CoA groups for synthesis of structural lipids indispensable for fast-growing neoplastic cells. Isocitrate NADP dehydrogenase, which also rises 12-fold in carcinoma, may be actively involved in this process for supplying reducing equivalents for fatty-acid synthesis (Bowman et al., 1966) .
Similar enzymatic activities in both breast carcinoma and metastatic lymph nodules indicate that histological identity reflects metabolic identity of primary and secondary foci.
